Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet

Global TravEpiNet Consortium

doi:10.4269/ajtmh.14-0062

Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet

Global TravEpiNet Consortium

Division of Pediatric Infectious Diseases
Tufts University
University of Massachusetts Medical School
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Massachusetts General Hospital
Saint Vincent Hospital Worcester
Mayo Clinic in Jacksonville, Florida
Kaiser Permanente
Chelsea HealthCare Center
St. Luke's-Roosevelt Hospital Center
Salt Lake Valley Health Department
Cornell University
Emory University
JourneyHealth
University of Southern California
University of Utah School of Medicine
Johns Hopkins University School of Medicine
Tulane University
Lehigh Valley Health Network
Northwestern Memorial Hospital
DeKalb County Board of Health Travel Services-DeKalb East
Revere HealthCare Center
Georgetown University
University of California San Francisco Center for Tuberculosis
HealthPartners
Department of Medicine

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

Original language	English
Pages (from-to)	694-698
Number of pages	5
Journal	American Journal of Tropical Medicine and Hygiene
Volume	91
Issue number	4
DOIs	https://doi.org/10.4269/ajtmh.14-0062
State	Published - 1 Oct 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.4269/ajtmh.14-0062

Cite this

@article{7df911b678bc491cbd2f1f1739d9b724,

title = "Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet",

abstract = "Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70\% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.",

author = "\{Global TravEpiNet Consortium\} and Deshpande, \{Bhushan R.\} and Rao, \{Sowmya R.\} and Jentes, \{Emily S.\} and Hills, \{Susan L.\} and Marc Fischer and Gershman, \{Mark D.\} and Brunette, \{Gary W.\} and Ryan, \{Edward T.\} and LaRocque, \{Regina C.\} and Abraham, \{George M.\} and Salvador Alvarez and Vernon Ansdell and Yates, \{Johnnie A.\} and Atkins, \{Elisha H.\} and John Cahill and Birich, \{Holly K.\} and Dagmar Vitek and Connor, \{Bradley A.\} and Roberta Dismukes and Jessica Fairley and Phyllis Kozarsky and Ronke Dosunmu and Goad, \{Jeffrey A.\} and Edith Mirzaian and Brian Kendall and Hale, \{De Von\} and Hynes, \{Noreen A.\} and Frederique Jacquerioz and Susan McLellan and Mark Knouse and Jennifer Lee and Alawode Oladele and Hanna Demeke and Roger Pasinski and Wheeler, \{Amy E.\} and Jessica Rosen and Cabellon, \{Noreen N.\} and Schwartz, \{Brian S.\} and William Stauffer and Patricia Walker and Joseph Vinetz",

note = "Publisher Copyright: Copyright {\textcopyright} 2014 by The American Society of Tropical Medicine and Hygiene.",

year = "2014",

month = oct,

day = "1",

doi = "10.4269/ajtmh.14-0062",

language = "Ingl{\'e}s",

volume = "91",

pages = "694--698",

journal = "American Journal of Tropical Medicine and Hygiene",

issn = "0002-9637",

number = "4",

}

TY - JOUR

T1 - Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet

AU - Global TravEpiNet Consortium

AU - Deshpande, Bhushan R.

AU - Rao, Sowmya R.

AU - Jentes, Emily S.

AU - Hills, Susan L.

AU - Fischer, Marc

AU - Gershman, Mark D.

AU - Brunette, Gary W.

AU - Ryan, Edward T.

AU - LaRocque, Regina C.

AU - Abraham, George M.

AU - Alvarez, Salvador

AU - Ansdell, Vernon

AU - Yates, Johnnie A.

AU - Atkins, Elisha H.

AU - Cahill, John

AU - Birich, Holly K.

AU - Vitek, Dagmar

AU - Connor, Bradley A.

AU - Dismukes, Roberta

AU - Fairley, Jessica

AU - Kozarsky, Phyllis

AU - Dosunmu, Ronke

AU - Goad, Jeffrey A.

AU - Mirzaian, Edith

AU - Kendall, Brian

AU - Hale, De Von

AU - Hynes, Noreen A.

AU - Jacquerioz, Frederique

AU - McLellan, Susan

AU - Knouse, Mark

AU - Lee, Jennifer

AU - Oladele, Alawode

AU - Demeke, Hanna

AU - Pasinski, Roger

AU - Wheeler, Amy E.

AU - Rosen, Jessica

AU - Cabellon, Noreen N.

AU - Schwartz, Brian S.

AU - Stauffer, William

AU - Walker, Patricia

AU - Vinetz, Joseph

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

AB - Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to August of 2012. Higher-risk travelers were younger than lower-risk travelers (median age = 29 years versus 40 years, P < 0.001). Over 70% of higher-risk travelers neither received JE vaccine during the clinic visit nor had been previously vaccinated. In the majority of these instances, clinicians determined that the JE vaccine was not indicated for the higher-risk traveler, which contradicts current recommendations of the Advisory Committee on Immunization Practices. Better understanding is needed of the clinical decision-making regarding JE vaccine in US travel medicine practices.

UR - https://www.scopus.com/pages/publications/84907705156

U2 - 10.4269/ajtmh.14-0062

DO - 10.4269/ajtmh.14-0062

M3 - Artículo

C2 - 25070999

AN - SCOPUS:84907705156

SN - 0002-9637

VL - 91

SP - 694

EP - 698

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

IS - 4

ER -

Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this